643 related articles for article (PubMed ID: 32582206)
21. Functional and Activation Profiles of Mucosal-Associated Invariant T Cells in Patients With Tuberculosis and HIV in a High Endemic Setting.
Balfour A; Schutz C; Goliath R; Wilkinson KA; Sayed S; Sossen B; Kanyik JP; Ward A; Ndzhukule R; Gela A; Lewinsohn DM; Lewinsohn DA; Meintjes G; Shey M
Front Immunol; 2021; 12():648216. PubMed ID: 33828558
[No Abstract] [Full Text] [Related]
22. Mucosal-Associated Invariant T Cells Are Depleted and Exhibit Altered Chemokine Receptor Expression and Elevated Granulocyte Macrophage-Colony Stimulating Factor Production During End-Stage Renal Disease.
Juno JA; Waruk JLM; Wragg KM; Mesa C; Lopez C; Bueti J; Kent SJ; Ball TB; Kiazyk SA
Front Immunol; 2018; 9():1076. PubMed ID: 29868028
[TBL] [Abstract][Full Text] [Related]
23. Mucosal associated invariant T cells from human breast ducts mediate a Th17-skewed response to bacterially exposed breast carcinoma cells.
Zumwalde NA; Haag JD; Gould MN; Gumperz JE
Breast Cancer Res; 2018 Sep; 20(1):111. PubMed ID: 30208917
[TBL] [Abstract][Full Text] [Related]
24. Human liver-derived MAIT cells differ from blood MAIT cells in their metabolism and response to TCR-independent activation.
Lamichhane R; Munro F; Harrop TWR; de la Harpe SM; Dearden PK; Vernall AJ; McCall JL; Ussher JE
Eur J Immunol; 2021 Apr; 51(4):879-892. PubMed ID: 33368232
[TBL] [Abstract][Full Text] [Related]
25. Role of MAIT cells in pulmonary bacterial infection.
Hartmann N; Harriff MJ; McMurtrey CP; Hildebrand WH; Lewinsohn DM; Kronenberg M
Mol Immunol; 2018 Sep; 101():155-159. PubMed ID: 29940408
[TBL] [Abstract][Full Text] [Related]
26. The Immune Modulating Properties of Mucosal-Associated Invariant T Cells.
Ioannidis M; Cerundolo V; Salio M
Front Immunol; 2020; 11():1556. PubMed ID: 32903532
[TBL] [Abstract][Full Text] [Related]
27. Opsonization-Enhanced Antigen Presentation by MR1 Activates Rapid Polyfunctional MAIT Cell Responses Acting as an Effector Arm of Humoral Antibacterial Immunity.
Boulouis C; Gorin JB; Dias J; Bergman P; Leeansyah E; Sandberg JK
J Immunol; 2020 Jul; 205(1):67-77. PubMed ID: 32434941
[TBL] [Abstract][Full Text] [Related]
28. TCR- or Cytokine-Activated CD8
Lamichhane R; Schneider M; de la Harpe SM; Harrop TWR; Hannaway RF; Dearden PK; Kirman JR; Tyndall JDA; Vernall AJ; Ussher JE
Cell Rep; 2019 Sep; 28(12):3061-3076.e5. PubMed ID: 31533031
[TBL] [Abstract][Full Text] [Related]
29. Mucosal-associated invariant T cell receptor recognition of small molecules presented by MR1.
Awad W; Le Nours J; Kjer-Nielsen L; McCluskey J; Rossjohn J
Immunol Cell Biol; 2018 Jul; 96(6):588-597. PubMed ID: 29393543
[TBL] [Abstract][Full Text] [Related]
30. Human MAIT Cell Activation In Vitro.
Hagel JP; Garner LC; Bilton M; Mehta H; Leng T; Hackstein CP; Phalora P; Amini A; Akther HD; Provine NM; Edmans M; Willberg CB; Klenerman P
Methods Mol Biol; 2020; 2098():97-124. PubMed ID: 31792818
[TBL] [Abstract][Full Text] [Related]
31. Multiple layers of heterogeneity and subset diversity in human MAIT cell responses to distinct microorganisms and to innate cytokines.
Dias J; Leeansyah E; Sandberg JK
Proc Natl Acad Sci U S A; 2017 Jul; 114(27):E5434-E5443. PubMed ID: 28630305
[TBL] [Abstract][Full Text] [Related]
32. Varicella Zoster Virus infects mucosal associated Invariant T cells.
Purohit SK; Corbett AJ; Slobedman B; Abendroth A
Front Immunol; 2023; 14():1121714. PubMed ID: 37006246
[TBL] [Abstract][Full Text] [Related]
33. Alternative splicing of MR1 regulates antigen presentation to MAIT cells.
Narayanan GA; Nellore A; Tran J; Worley AH; Meermeier EW; Karamooz E; Huber ME; Kurapova R; Tafesse FG; Harriff MJ; Lewinsohn DM
Sci Rep; 2020 Sep; 10(1):15429. PubMed ID: 32963314
[TBL] [Abstract][Full Text] [Related]
34. Activation, Deficiency, and Reduced IFN-γ Production of Mucosal-Associated Invariant T Cells in Patients with Inflammatory Bowel Disease.
Ju JK; Cho YN; Park KJ; Kwak HD; Jin HM; Park SY; Kim HS; Kee SJ; Park YW
J Innate Immun; 2020; 12(5):422-434. PubMed ID: 32535589
[TBL] [Abstract][Full Text] [Related]
35. TLR signaling in human antigen-presenting cells regulates MR1-dependent activation of MAIT cells.
Ussher JE; van Wilgenburg B; Hannaway RF; Ruustal K; Phalora P; Kurioka A; Hansen TH; Willberg CB; Phillips RE; Klenerman P
Eur J Immunol; 2016 Jul; 46(7):1600-14. PubMed ID: 27105778
[TBL] [Abstract][Full Text] [Related]
36. MAIT Cells in COVID-19: Heroes, Villains, or Both?
Haeryfar SMM
Crit Rev Immunol; 2020; 40(2):173-184. PubMed ID: 32749095
[TBL] [Abstract][Full Text] [Related]
37. Type I interferons are important co-stimulatory signals during T cell receptor mediated human MAIT cell activation.
Lamichhane R; Galvin H; Hannaway RF; de la Harpe SM; Munro F; Tyndall JD; Vernall AJ; McCall JL; Husain M; Ussher JE
Eur J Immunol; 2020 Feb; 50(2):178-191. PubMed ID: 31608441
[TBL] [Abstract][Full Text] [Related]
38. Biliary epithelium and liver B cells exposed to bacteria activate intrahepatic MAIT cells through MR1.
Jeffery HC; van Wilgenburg B; Kurioka A; Parekh K; Stirling K; Roberts S; Dutton EE; Hunter S; Geh D; Braitch MK; Rajanayagam J; Iqbal T; Pinkney T; Brown R; Withers DR; Adams DH; Klenerman P; Oo YH
J Hepatol; 2016 May; 64(5):1118-1127. PubMed ID: 26743076
[TBL] [Abstract][Full Text] [Related]
39. MAIT cells as attractive vaccine targets.
Downey AM; Kapłonek P; Seeberger PH
FEBS Lett; 2019 Jul; 593(13):1627-1640. PubMed ID: 31206659
[TBL] [Abstract][Full Text] [Related]
40. IL-33 Enhances IFNγ and TNFα Production by Human MAIT Cells: A New Pro-Th1 Effect of IL-33.
Azzout M; Dietrich C; Machavoine F; Gastineau P; Bottier A; Lezmi G; Leite-de-Moraes M
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
